aspirin has been researched along with Epithelial Ovarian Cancer in 10 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aspirin use was associated with a reduced risk of ovarian cancer (OR = 0." | 6.50 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. ( Anton-Culver, H; Bandera, EV; Berchuck, A; Brinton, LA; Chandran, U; Cramer, DW; Doherty, JA; Gayther, SA; Gentry-Maharaj, A; Goode, EL; Goodman, MT; Hogdall, E; Jensen, A; Jordan, SJ; King, MG; Kjær, SK; Lo-Ciganic, WH; Lurie, G; Menon, U; Murphy, MA; Nagle, CM; Ness, RB; Olson, S; Pearce, CL; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rossing, MA; Schildkraut, JM; Terry, KL; Trabert, B; Vitonis, A; Webb, PM; Wentzensen, N; Wu, AH; Ziogas, A, 2014) |
| "We examined the association between postdiagnosis use of low-dose aspirin and mortality in a nationwide cohort of women with epithelial ovarian cancer between 2000 and 2012." | 3.88 | Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study. ( Dehlendorff, C; Friis, S; Kjaer, SK; Verdoodt, F, 2018) |
| "Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% CIs for associations of aspirin, nonaspirin NSAIDs, and acetaminophen with risk of epithelial ovarian cancer." | 3.88 | Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies. ( Barnard, ME; Curhan, GC; Eliassen, AH; Poole, EM; Rosner, BA; Terry, KL; Tworoger, SS, 2018) |
| "Aspirin use was associated with a reduced risk of ovarian cancer (OR = 0." | 2.50 | Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. ( Anton-Culver, H; Bandera, EV; Berchuck, A; Brinton, LA; Chandran, U; Cramer, DW; Doherty, JA; Gayther, SA; Gentry-Maharaj, A; Goode, EL; Goodman, MT; Hogdall, E; Jensen, A; Jordan, SJ; King, MG; Kjær, SK; Lo-Ciganic, WH; Lurie, G; Menon, U; Murphy, MA; Nagle, CM; Ness, RB; Olson, S; Pearce, CL; Pike, MC; Poole, EM; Ramus, SJ; Risch, HA; Rossing, MA; Schildkraut, JM; Terry, KL; Trabert, B; Vitonis, A; Webb, PM; Wentzensen, N; Wu, AH; Ziogas, A, 2014) |
| "The findings of this study suggest that genetic susceptibility to ovarian cancer based on currently identified common genetic variants does not appear to modify the protective association between frequent aspirin use and ovarian cancer risk." | 1.91 | Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. ( Anton-Culver, H; Berchuck, A; Doherty, JA; Goodman, MT; Harris, HR; Hurwitz, LM; Jordan, SJ; Menon, U; Modugno, F; Moysich, KB; Pearce, CL; Pharoah, PDP; Ramus, SJ; Schildkraut, JM; Shvetsov, YB; Trabert, B; Tworoger, SS; Webb, PM; Wentzensen, N; Wu, AH; Ziogas, A, 2023) |
| "The cases were all women in Denmark with epithelial ovarian cancer diagnosed during 2000-2009 (Paper 1) and 2000-2011 (Papers 2 and 3), identified in the Cancer Registry." | 1.42 | Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study. ( Baandrup, L, 2015) |
| "Aspirin use was associated with a marginally significant reduction in incidence of VTEs within 2 years of diagnosis, HR 0." | 1.40 | Statins, aspirin and risk of thromboembolic events in ovarian cancer patients. ( Lavie, O; Leviov, M; Rennert, G; Rennert, HS; Sagi, S; Shai, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinha, BK | 1 |
| Tokar, EJ | 1 |
| Bortner, CD | 1 |
| Hurwitz, LM | 1 |
| Webb, PM | 2 |
| Jordan, SJ | 2 |
| Doherty, JA | 2 |
| Harris, HR | 1 |
| Goodman, MT | 2 |
| Shvetsov, YB | 1 |
| Modugno, F | 1 |
| Moysich, KB | 1 |
| Schildkraut, JM | 2 |
| Berchuck, A | 2 |
| Anton-Culver, H | 2 |
| Ziogas, A | 2 |
| Menon, U | 2 |
| Ramus, SJ | 2 |
| Wu, AH | 2 |
| Pearce, CL | 2 |
| Wentzensen, N | 2 |
| Tworoger, SS | 3 |
| Pharoah, PDP | 1 |
| Trabert, B | 2 |
| Verdoodt, F | 1 |
| Kjaer, SK | 1 |
| Dehlendorff, C | 1 |
| Friis, S | 1 |
| Merritt, MA | 1 |
| Rice, MS | 1 |
| Barnard, ME | 2 |
| Hankinson, SE | 1 |
| Matulonis, UA | 1 |
| Poole, EM | 3 |
| Curhan, GC | 1 |
| Eliassen, AH | 1 |
| Rosner, BA | 1 |
| Terry, KL | 2 |
| Tsoref, D | 1 |
| Panzarella, T | 1 |
| Oza, A | 1 |
| Ness, RB | 1 |
| Lo-Ciganic, WH | 1 |
| Murphy, MA | 1 |
| Goode, EL | 1 |
| Brinton, LA | 1 |
| Nagle, CM | 1 |
| Risch, HA | 1 |
| Rossing, MA | 1 |
| Lurie, G | 1 |
| Kjær, SK | 1 |
| Hogdall, E | 1 |
| Jensen, A | 1 |
| Cramer, DW | 1 |
| Vitonis, A | 1 |
| Bandera, EV | 1 |
| Olson, S | 1 |
| King, MG | 1 |
| Chandran, U | 1 |
| Gayther, SA | 1 |
| Gentry-Maharaj, A | 1 |
| Pike, MC | 1 |
| Shai, A | 1 |
| Rennert, HS | 1 |
| Rennert, G | 1 |
| Sagi, S | 1 |
| Leviov, M | 1 |
| Lavie, O | 1 |
| Baandrup, L | 1 |
| Chiyoda, T | 1 |
| Hart, PC | 1 |
| Eckert, MA | 1 |
| McGregor, SM | 1 |
| Lastra, RR | 1 |
| Hamamoto, R | 1 |
| Nakamura, Y | 1 |
| Yamada, SD | 1 |
| Olopade, OI | 1 |
| Lengyel, E | 1 |
| Romero, IL | 1 |
1 review available for aspirin and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Australia; | 2014 |
9 other studies available for aspirin and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Molecular Mechanisms of Cytotoxicity of NCX4040, the Non-Steroidal Anti-Inflammatory NO-Donor, in Human Ovarian Cancer Cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Carcinoma, Ovarian Epitheli | 2022 |
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.
Topics: Aged; Aspirin; Carcinoma, Ovarian Epithelial; Female; Genetic Predisposition to Disease; Humans; Log | 2023 |
Aspirin use and ovarian cancer mortality in a Danish nationwide cohort study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Carcinoma, Ovarian Epithelial; Cohort Studies; Denmark; Fem | 2018 |
Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
Topics: Acetaminophen; Adult; Aged; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, | 2018 |
Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Ovarian Epithelial; | 2018 |
Aspirin in prevention of ovarian cancer: are we at the tipping point?
Topics: Acetaminophen; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Carcinoma, | 2014 |
Statins, aspirin and risk of thromboembolic events in ovarian cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Carcinoma, Ovarian Epithelial; | 2014 |
Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Topics: Academic Dissertations as Topic; Acetaminophen; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narc | 2015 |
Loss of BRCA1 in the Cells of Origin of Ovarian Cancer Induces Glycolysis: A Window of Opportunity for Ovarian Cancer Chemoprevention.
Topics: Aspirin; BRCA1 Protein; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Chemoprevention; Cyclooxyge | 2017 |